v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 602,444 $ 547,890
Investments held in marketable securities 3,887,383 10,184,701
Accounts receivable 13,400 188,400
Prepaid expenses and other current assets 204,237 223,230
Total Current Assets 4,707,464 11,144,221
Deferred offering costs 69,066 148,697
Property and equipment, net 309,498 362,936
Intangible assets, net 556,634 623,945
Total Assets 5,642,662 12,279,799
Current Liabilities:    
Accounts payable 859,898 483,070
Accrued expenses and other current liabilities 607,470 744,485
Warrant liabilities 1,968,315 2,520,851
Total Current Liabilities 3,435,683 3,748,406
Commitments and contingencies
Stockholders’ Equity:    
Preferred stock, $0.01 par value; 20,000,000 shares authorized; Series B Convertible Preferred Stock; 1,543,158 shares designated, 1,398,158 shares issued and outstanding at September 30, 2025 and December 31, 2024 13,982 13,982
Common stock, $0.0001 par value; 75,000,000 shares authorized; 7,978,117 and 6,919,919 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 797 692
Additional paid-in capital 168,905,254 164,195,434
Accumulated deficit (166,713,054) (155,678,715)
Total Stockholders’ Equity 2,206,979 8,531,393
Total Liabilities and Stockholders’ Equity $ 5,642,662 $ 12,279,799

Source

10-Q XBRL Zip